A California-based genomics company has announced it will begin selling an over-the-counter DNA test it claims could offer clues as to whether individuals will become obese, have the risk of losing their eyesight or carry the genes for certain diseases that could be passed on to their children, The Washington Post reports. The kit is set to hit the shelves at 6,000 branches of one national drugstore chain today. However, the report states, the plan has bioethicists, federal regulators and others concerned that it could be a "Pandora's box of confusion, privacy violations, genetic discrimination and other issues." The Food and Drug Administration (FDA) has indicated it will investigate the test, which does not have FDA approval. (Registration may be required to access this story.)
If you want to comment on this post, you need to login.